Rising global chip sales and AI-driven demand put ADI, NVDA, MTSI and ASYS in focus as semiconductor stocks gain momentum in a strong market.

JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic manufacturing.

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

PBF Energy soared 14% on a robust gap-and-go following a Piper Sandler upgrade to ‘Overweight' accompanied by a $40 price target. The catalyst mentioned was PBF‘s strategic advantage in increasing Venezuelan crude imports.

The U.S. involvement in Venezuela's oil sector offers a potential opportunity for international banks, with JPMorgan Chase in an advantageous spot due to its history in the country and past involvement with international trade financing.

Despite tariff worries and equity outflows, India's growth story makes its ETFs a compelling play.

In a move to align management responsibilities with its evolving business strategy, Navient Corporation NAVI has revised its leadership structure. As part of the move, Steve Hauber, previously executive vice president (EVP) and chief administrative officer, has been appointed EVP and chief financial officer (CFO), effective immediately.

PSTL's 2025 results show steady expansion, with 216 USPS-leased property buys, near-100% occupancy and a fixed-rate balance sheet.

VRSK shares beat industry gains as subscription shift, SaaS demand and new AI tools drive revenue growth across underwriting and claims.

NEW YORK--(BUSINESS WIRE)---- $AQST #AQST--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. Shares of Aquestive Therapeutics, Inc. (NA.

The biotechnology sector's strong fundamentals and robust innovation could continue to drive outperformance this year, according to Baird analysts. The firm noted that while macroeconomic risks such as rising interest rates remain, the biotechnology sector's underlying drivers are supportive.

INOD's early lead in agentic AI evaluation may fuel 2026 growth as enterprises demand safer, scalable AI systems.

A headline of +50K is lower than the downwardly revised +56K the previous month, but the Unemployment Rate fell -20 bps to +4.4%.

IONQ ramps R&D and expands globally, but shares lag peers and trade at a steep P/S as QBTS and RGTI post advances.

OWLT's growing data flywheel and AI plans aim to deepen engagement, boost subscriptions, and extend customer value.

AEM's ultra-low debt, surging free cash flow and strong gold prices boost its growth potential and shareholder returns.

APH and ADI stand out in the AI boom, supported by the massive growth of cloud computing and data centers.

Lumentum's stock has quadrupled over the past year, but the optical component company plays into key AI themes that could fuel further gains.

SANTIAGO, Chile, Jan. 09, 2026 (GLOBE NEWSWIRE) -- You are cordially invited to participate in Banco Santander Chile's (NYSE: BSAC) conference call-webcast on Thursday February 5, 2026, at 9.00 AM NY time (11.00am Chile time) where we will discuss 4Q 2025 financial results. The Bank's Officers participating in the conference call are: Patricia Pérez, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR and Lorena Palomeque, Economist. A question and answer session will follow the presentation.

Paramount Skydance is still trying to disrupt Warner Bros. Discovery's deal with Netflix.